Blocking exosomal secretion aggravated 1,4-benzoquinone-induced cytotoxicity

Environ Toxicol. 2024 Mar;39(3):1099-1106. doi: 10.1002/tox.23944. Epub 2023 Oct 11.

Abstract

Benzene exposure inhibits the hematopoietic system and leads to the occurrence of various types of leukemia. However, the mechanism underlying the hematotoxicity of benzene is still largely unclear. Emerging evidence has shown that exosomes are involved in toxic mechanisms of benzene. To understand the effect of 1,4-benzoquinone (PBQ; an active metabolite of benzene in bone marrow) on the exosomal release characteristics and role of exosomal secretion in PBQ-induced cytotoxicity. Exosomes were isolated from PBQ-treated HL-60 cells, purified by ultracentrifugation, and verified by transmission electron microscopy, nanoparticle tracking analysis and the presence of specific biomarkers. Our results showed that PBQ increased exosomal secretion in a dose-dependent manner, reaching a peak in 3 h at 10 μM PBQ treatment and then slowly decreasing in HL-60 cells. The exosomes contained miRNAs, which have been reported to be associated with benzene exposure or benzene poisoning. In particular, mir-34a-3p and mir-34A-5p were enriched in exosomes derived from PBQ-treated cells. In addition, the inhibition of exosomal release by GW4869 (an inhibitor of exosomal release) exacerbated PBQ-induced cytotoxicity, including increased intracellular reactive oxygen species levels, decreased mitochondrial membrane potential, and increased the apoptosis rate. Our findings illustrated that exosomes secretion plays an important role in antagonizing PBQ-induced cytotoxicity and maintaining cell homeostasis.

Keywords: 1,4-benzoquinone; apoptosis; benzene; exosomes; miRNAs.

MeSH terms

  • Apoptosis
  • Benzene* / toxicity
  • Benzoquinones / pharmacology
  • HL-60 Cells
  • Humans
  • MicroRNAs* / metabolism

Substances

  • Benzene
  • MicroRNAs
  • Benzoquinones